Transformative Financing worth up to $275 million from Top-Tier Institutional Healthcare Investors ---- Advancement of IkT-001Pro into a ...

Get detailed information on Garenoxacin Mesylate, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated ...

Over the last 2 decades, significant progress has been made in our understanding of the genomics, tumor immune microenvironment, and immunogenicity of malignant melanoma. Historically, the prognosis ...

There are also oral medications in phase III based on a possible action against tau, such as simufilam and ...

Progress is being made to help lower the side effects of GLP-1 medication. A new study on NG101 (metopimazine mesylate), ...

For chronic myeloid leukemia (CML) patients, there is a promising new first-line drug approval with asciminib (brand name ...

Angiotensin II (AT-II)-Receptor Antagonists are Reviewed. Research focused on blocking the renin- angiotensin system (RAS) led to the discovery of angiotensin-converting-enzyme (ACE) inhibitors ...

Dihydroergotamine mesylate – generic, DHE 45® 1 mg/ml ampules 1 mg im. or sc.; can be repeated at 1 h intervals (max 3 mg/24 h, 6 mg/week) Migranal® nasal spray 4 mg/ml nasal spray One spray ...